Takeda Pharmaceutical Co. Ltd. - Total Cash From Operating Activities

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Total-Cash-From-Operating-Activities" stands at 1.13 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of 0.3782 Trillion JPY for the item "Total Cash From Operating Activities" represents an increase of 85.56 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of 0.3782 Trillion JPY for the item "Total Cash From Operating Activities" represents an increase of 46.03 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 1.13 Trillion JPY for the item "Total Cash From Operating Activities" represents an increase of 11.84 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.3143 Trillion Japanese Yens compared to the value the year prior.
The 1 year change is 0.3143 Trillion Japanese Yens.
The 3 year change is 0.1982 Trillion Japanese Yens.
The 5 year change is 0.5139 Trillion Japanese Yens.
The 10 year change is 0.9333 Trillion Japanese Yens.

The Serie's long term average value is 0.534 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 0.592 Trillion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 12/31/2016, to it's latest available value, on 09/30/2025, is +1.14 Trillion.
The Serie's change in Japanese Yens from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0 Trillion.